2003
DOI: 10.1023/a:1022364830421
|View full text |Cite
|
Sign up to set email alerts
|

Erucamide as a Modulator of Water Balance: New Function of a Fatty Acid Amide

Abstract: The aim of this study was to isolate a compound from blood plasma that inhibits intestinal diarrhea and that appears also to regulate fluid volumes in other organs. The isolation procedure included lipid extraction, liquid chromatography, and gas chromatography. The active substance was identified by mass spectrometry as erucamide (MW 337 Da). The biological effect was reproduced with authentic erucamide. Erucamide is a fatty acid amide, such as oleamide and anandamide, which modulate other physiological funct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 37 publications
(25 citation statements)
references
References 50 publications
1
24
0
Order By: Relevance
“…[9][10][11] Similarly, erucamide has previously been reported to possess angiogenic and fluid homeostatic activity in vivo. 12,13 Accordingly, we next sought to determine whether we could demonstrate biological activity of erucamide and OEA at a common biological target. Commercially obtained samples of erucamide and OEA as well as the erucamide-containing DMSO extracts prepared from the 50-µL pipette tips were tested for the ability to stimulate cyclic AMP (cAMP) accumulation in cells expressing a G-protein-coupled receptor (GPCR) known to be activated by fatty acid ligands.…”
Section: Resultsmentioning
confidence: 99%
“…[9][10][11] Similarly, erucamide has previously been reported to possess angiogenic and fluid homeostatic activity in vivo. 12,13 Accordingly, we next sought to determine whether we could demonstrate biological activity of erucamide and OEA at a common biological target. Commercially obtained samples of erucamide and OEA as well as the erucamide-containing DMSO extracts prepared from the 50-µL pipette tips were tested for the ability to stimulate cyclic AMP (cAMP) accumulation in cells expressing a G-protein-coupled receptor (GPCR) known to be activated by fatty acid ligands.…”
Section: Resultsmentioning
confidence: 99%
“…Fatty acids were dissolved in ethanol, converted to the sodium salt with excess NaOH, dried under vacuum, and then dissolved in phosphate-buffered saline (PBS) to make a 25 mM solution. The sample was then heated in 49°C water bath for 5 min before angiogenesis ( 25 ) and controls water balance ( 26 ). In addition, both mammalian phospholipase A 2 (PLA 2 ) and epoxide hydrolase (EH) are inhibited by series of PFAMs, with arachidonamide and ␥ -linolenamide being the most potent for the inhibition of PLA 2 ( 27 ) and elaidamide being the most potent for the inhibition of EH ( 28 ).…”
Section: Use Of Bsa As a Fatty Acid Carriermentioning
confidence: 99%
“…[96,97] for reviews]. Like oleamide, other members of the PFAM are bioactive: linoleamide increases Ca 2+ flux [98] and inhibits the erg current in pituitary cells [99], erucamide stimulates the growth of blood vessels [100] and regulates fluid imbalance [101] and elaidamide might function as an endogenous inhibitor of epoxide hydrolase [102].…”
Section: Primary Fatty Acid Amidesmentioning
confidence: 99%